Endocrine Abstracts

IntroductionSolriamfetol is a dopamine and norepinephrine reuptake inhibitor, indicated to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (OSA). Decrease in the body weight as an adverse effect of < 2% incidence in both the narcolepsy and OSA patients has been reported. We hypothesise that the baseline Body Mass Index (BMI) may be a an independent predictive marker for the...

Introduction: Obesity and diabetes are the known risk factors for severity and susceptibility to severe COVID-19 with a poor prognosis. However, there is limited evidence for the implications and association of metabolic factors on COVID-19 vaccination.Methods: We systematically searched PubMed/Medline and Cochrane library till January 28, 2022, using: (“diabetes OR BMI OR weight OR glucose OR obesity OR metabolic” and “COVID OR Coronaviru...